Τετάρτη 31 Αυγούστου 2016

Superior Therapeutic Index in Lymphoma Therapy: CD30+ CD34+ Hematopoietic Stem Cells Resist a Chimeric Antigen Receptor T-cell Attack

Superior Therapeutic Index in Lymphoma Therapy: CD30+ CD34+ Hematopoietic Stem Cells Resist a Chimeric Antigen Receptor T-cell Attack

Molecular Therapy 24, 1423 (August 2016). doi:10.1038/mt.2016.82

Authors: Andreas A Hombach, André Görgens, Markus Chmielewski, Florian Murke, Janine Kimpel, Bernd Giebel & Hinrich Abken



from Cancer via ola Kala on Inoreader http://ift.tt/2bCpCjF
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου